DANIEL LEUNG to Liver
This is a "connection" page, showing publications DANIEL LEUNG has written about Liver.
Connection Strength
1.521
-
The Emergence of Elastography for Cystic Fibrosis Liver Disease. J Cyst Fibros. 2020 05; 19(3):339-341.
Score: 0.418
-
Drug-induced liver injury in children. Curr Opin Pediatr. 2015 Oct; 27(5):625-33.
Score: 0.304
-
Serum biomarkers correlated with liver stiffness assessed in a multicenter study of pediatric cholestatic liver disease. Hepatology. 2023 02 01; 77(2):530-545.
Score: 0.124
-
Long-term follow-up and liver outcomes in children with cystic fibrosis and nodular liver on ultrasound in a multi-center study. J Cyst Fibros. 2023 03; 22(2):248-255.
Score: 0.122
-
Heterogeneous Liver on Research Ultrasound Identifies Children with Cystic Fibrosis at High Risk of Advanced Liver Disease: Interim Results of a Prospective Observational Case-Controlled Study. J Pediatr. 2020 04; 219:62-69.e4.
Score: 0.103
-
A Multidisciplinary Approach to Pretransplant and Posttransplant Management of Cystic Fibrosis-Associated Liver Disease. Liver Transpl. 2019 04; 25(4):640-657.
Score: 0.097
-
Aspartate aminotransferase to platelet ratio and fibrosis-4 as biomarkers in biopsy-validated pediatric cystic fibrosis liver disease. Hepatology. 2015 Nov; 62(5):1576-83.
Score: 0.076
-
High prevalence of hepatitis B nonimmunity in vaccinated pediatric liver transplant recipients. Am J Transplant. 2015 Feb; 15(2):535-40.
Score: 0.072
-
Imaging-based noninvasive liver disease assessment for staging liver fibrosis in chronic liver disease: A systematic review supporting the AASLD Practice Guideline. Hepatology. 2025 Feb 01; 81(2):725-748.
Score: 0.034
-
Prospective study of quantitative liver MRI in cystic fibrosis: feasibility and comparison to PUSH cohort ultrasound. Pediatr Radiol. 2023 10; 53(11):2210-2220.
Score: 0.033
-
Heterogeneous liver on research ultrasound identifies children with cystic fibrosis at high risk of advanced liver disease. J Cyst Fibros. 2023 07; 22(4):745-755.
Score: 0.032
-
Gamma-glutamyl transpeptidase-to-platelet ratio as a biomarker of liver disease and hepatic fibrosis severity in paediatric Cystic Fibrosis. J Cyst Fibros. 2022 03; 21(2):236-242.
Score: 0.029
-
Biomarkers for liver disease in urea cycle disorders. Mol Genet Metab. 2021 06; 133(2):148-156.
Score: 0.028
-
Hepatic Steatosis Is Prevalent Following Orthotopic Liver Transplantation in Children With Cystic Fibrosis. J Pediatr Gastroenterol Nutr. 2019 01; 68(1):96-103.
Score: 0.024
-
MicroRNA Sequencing Identifies a Serum MicroRNA Panel, Which Combined With Aspartate Aminotransferase to Platelet Ratio Index Can Detect and Monitor Liver Disease in Pediatric Cystic Fibrosis. Hepatology. 2018 12; 68(6):2301-2316.
Score: 0.024